We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+20.65%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$100M
AUM Growth
+$24.3M
(+32%)
Cap. Flow
+$6.54M
Cap. Flow
% of AUM
6.51%
Top 10 Holdings %
Top 10 Hldgs %
56.12%
Holding
218
New
50
Increased
37
Reduced
21
Closed
27
Avg Time Held Equity + Options
4.4
quarters
Top 10 Avg Time Held Equity + Options
1.9
quarters
Top 20 Avg Time Held Equity + Options
2.2
quarters
Avg Time Held Equity only
4.7
quarters
Top 10 Avg Time Held Equity only
2.6
quarters
Top 20 Avg Time Held Equity only
2.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.77M |
| 2 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
+$661K |
| 3 |
Agios Pharmaceuticals
AGIO
|
+$653K |
| 4 |
Micron Technology
MU
|
+$610K |
| 5 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$487K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.06M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$823K |
| 3 |
HTWR
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
|
+$578K |
| 4 |
BVA
CORDIA BANCORP INC COM
BVA
|
+$499K |
| 5 |
Opko Health
OPK
|
+$349K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 43.64% |
| 2 | Miscellaneous | 21.13% |
| 3 | Healthcare | 14.92% |
| 4 | Technology | 7.13% |
| 5 | Consumer Discretionary | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Applied Optoelectronics
AAOI
$8.55B
| $333K | 0.33% |
15,000
-18,000
| -55% | -$279K |
2016 Q1
2 quarters
|
|
|
HLND
52
DELISTED
HILAND PARTNERS, LP COMMON UNITS
HLND
| $321K | 0.32% |
70,655
-2,835
| -4% | -$12.9K |
2014 Q2
9 quarters
|
|
53
Pacific Biosciences
PACB
$653M
| $314K | 0.31% |
35,000
+5,000
| +17% | +$41.8K |
2015 Q4
3 quarters
|
|
|
CPE
54
CALL
DELISTED
Callon Petroleum Company
CPE
| $314K | 0.31% |
+2,000
| New | +$265K |
2016 Q3
0 quarters
|
|
55
Seres Therapeutics
MCRB
$26.9M
| $307K | 0.31% |
+1,250
| New | +$439K |
2016 Q3
0 quarters
|
|
56
DELISTED
ChemoCentryx, Inc.
CCXI
| $302K | 0.3% |
50,000
+25,000
| +100% | +$118K |
2016 Q2
1 quarter
|
|
|
FNSR
57
DELISTED
Finisar Corp
FNSR
| $298K | 0.3% |
+10,000
| New | +$219K |
2016 Q3
0 quarters
|
|
|
ZAYO
58
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $297K | 0.3% |
10,000
| – | – |
2016 Q2
1 quarter
|
|
|
MNDT
59
CALL
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $295K | 0.29% |
20,000
-30,000
| -60% | -$461K |
2016 Q2
1 quarter
|
|
60
UNIFI
UFI
$112M
| $294K | 0.29% |
10,000
| – | – |
2016 Q2
1 quarter
|
|
61
Callaway Golf Company
CALY
$2.45B
| $290K | 0.29% |
25,000
+10,000
| +67% | +$112K |
2015 Q4
3 quarters
|
|
62
DELISTED
Novadaq Technologies Inc.
NVDQ
| $289K | 0.29% |
25,000
+10,000
| +67% | +$109K |
2016 Q1
2 quarters
|
|
63
Las Vegas Sands
LVS
$23.4B
| $288K | 0.29% |
5,000
| – | – |
2015 Q4
3 quarters
|
|
64
McDonald's
MCD
$167B
| $277K | 0.28% |
2,400
| – | – |
2015 Q1
6 quarters
|
|
65
DELISTED
Paramount Global Class B
PARA
| $274K | 0.27% |
+5,000
| New | +$265K |
2016 Q3
0 quarters
|
|
|
CSLT
66
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $270K | 0.27% |
65,000
+15,000
| +30% | +$61.3K |
2014 Q1
10 quarters
|
|
|
67
CALL
Opko Health
OPK
$1.03B
| $265K | 0.26% |
+25,000
| New | +$249K |
2016 Q3
0 quarters
|
|
68
DELISTED
Bank of America Corporation Depositary Shares, each representing a 1/1,000 th interest in a share of
BAC.PRA
| $263K | 0.26% |
10,000
-5,000
| -33% | -$132K |
2016 Q2
1 quarter
|
|
|
LCAHU
69
DELISTED
Landcadia Holdings, Inc. Unit
LCAHU
| $256K | 0.26% |
25,000
| – | – |
2016 Q2
1 quarter
|
|
70
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $253K | 0.25% |
+15,000
| New | +$247K |
2016 Q3
0 quarters
|
|
|
SOJB
71
DELISTED
The Southern Company Series 2016A 5.25% Junior Subordinated Notes due October 1, 2076
SOJB
| – | – |
0
| – | – |
2016 Q3
0 quarters
|
|
|
NOVN
72
DELISTED
Novan, Inc. Common Stock
NOVN
| $252K | 0.25% |
+1,250
| New | +$261K |
2016 Q3
0 quarters
|
|
|
FRE.PRZ
73
DELISTED
FREDDIE MAC FIXED FLG RT NON CUM PERP PREF
FRE.PRZ
| $244K | 0.24% |
70,000
| – | – |
2013 Q2
13 quarters
|
|
|
FRGI
74
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $240K | 0.24% |
+10,000
| New | +$242K |
2016 Q3
0 quarters
|
|
|
SHOR
75
DELISTED
ShoreTel, Inc.
SHOR
| $240K | 0.24% |
+30,000
| New | +$235K |
2016 Q3
0 quarters
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q3 2016 Portfolio in Review
As of Q3 2016, E.E. Geduld held 218 positions worth $100M, up 32% from $76M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
E.E. Geduld deployed $6.54M of net new capital in Q3 2016, opening 50 new positions and adding to 37 existing holdings. Its largest new stake was Agios Pharmaceuticals: 15,000 shares worth $792K.
By sector, the portfolio is most concentrated in Financials at 44% of assets, down from 49% a quarter earlier, followed by Miscellaneous and Healthcare.
On the sell side, the largest reduction was Opko Health, an estimated $349K trimmed.
- E.E. Geduld's largest Q3 2016 buy was Agios Pharmaceuticals: 15,000 shares worth $792K.
- E.E. Geduld added most to Bristol-Myers Squibb in Q3 2016, an estimated $1.77M increase.
- E.E. Geduld's biggest Q3 2016 reduction was Opko Health, cutting an estimated $349K.
- E.E. Geduld fully exited Tesla in Q3 2016, selling an estimated $1.06M.
- E.E. Geduld's ten largest holdings make up 56% of its $100M portfolio in Q3 2016.
- E.E. Geduld opened 50 new positions and closed 27 in Q3 2016.
- E.E. Geduld's portfolio value rose 32% quarter-over-quarter to $100M.
Based on E.E. Geduld's 13F filing for Q3 2016, filed 2 Nov 2016.